Stocknear Logo Stocknear
/
Popular
Login

Akari Therapeutics

1.21
0.11 (10.00%)
At close: Apr 17, 2025, 3:33 PM
1.21
0.00%
After-hours: Apr 17, 2025, 04:00 PM EDT

Akari Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
2.6M 3.85M 13.25M 9.36M 14.06M 5.73M 5.97M 28.11M 34.1M
n/a n/a n/a n/a n/a n/a n/a n/a 10.02M
n/a n/a n/a n/a n/a n/a 521.83K 142.24K 143.67K
n/a n/a n/a 0.00 n/a -0.00 585K 142.24K 142.17K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a -2.49M n/a -521.88K -1.03M -2.01M n/a n/a
353K 197K 99.54K 90.3K 229.2K n/a 585K 706.41K n/a
2.95M 4.34M 13.81M 11.63M 17.57M 10.27M 16.4M 28.81M 45.63M
n/a n/a n/a n/a n/a 5K 20K 55.9K 58.36K
47.61M 14K 16.88K 22.93K 27K 30K 33K 39.12K 39.37K
47.61M 14K 16.88K 22.93K 27K 35K 53K 237.26K 239.9K
50.56M 4.36M 13.83M 11.65M 17.59M 10.31M 16.45M 29.05M 45.87M
12.41M 1.67M 947K 1.79M 3.38M 1.23M 1.59M 1.97M 2.21M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
3.26M n/a n/a n/a n/a n/a n/a n/a n/a
4.24M 2.73M 7.95M 1.12M n/a 1.01M 1.84M 7.78M 7.66M
19.91M 4.58M 12.04M 6.09M 5.22M 5.46M 3.08M 9.02M 11.71M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
383K n/a n/a n/a n/a n/a n/a 48K 56.36K
8.42M n/a 946.66K 4.3M n/a 1.01M n/a 48K 56.36K
28.33M 4.58M 12.04M 6.09M 5.22M 6.47M 3.08M 9.07M 11.77M
3.26M n/a n/a n/a n/a n/a n/a n/a n/a
5.32M 1.32M 744.49K 475.97K 385K 31.99M 23.65M 22.93M 18.34M
-247.25M -227.46M -217.45M -199.71M -156.63M -138.24M -116.47M -107.51M -74.94M
-738K 51.15M -770.84K -540.97K -10.94M -12.24M -12.25M -236.25K -280.1K
22.23M -229K 1.79M 5.55M 12.38M 3.84M 13.38M 19.98M 34.1M
n/a n/a n/a n/a n/a n/a 521.83K 142.24K 10.02M

Create Price Alert on AKTX

Your price alert will notify you when the stock price is above 1.21.

Add to Watchlist